About PolyTechnos Venture Partners
PolyTechnos Venture Partners is a venture capital firm founded in 1998. It is primarily based out of Munich, Germany. As of May 2013, PolyTechnos Venture Partners has invested in 20 companies. It primarily invests in Series A round in Germany based startups. Its investments are spread across a wide range of sectors from Life Sciences to Auto Tech and High Tech. Most recently it participated in the $***** Series A round of Pixium Vision Overall, PolyTechnos Venture Partners portfolio has seen 2 IPOs and 7 acquisitions including key companies like Addex Therapeutics, ColorChip and Jerini. A lot of funds co-invest with PolyTechnos Venture Partners, with names like Abingworth sharing a substantial percentage of its portfolio. PolyTechnos Venture Partners has team of 6 people including 6 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series B, Series A & 3 more
Portfolio IPOs
PolyTechnos Venture Partners' List of Top Investments
PolyTechnos Venture Partners has a portfolio of 20 companies. Their most notable investments are in Jerini and vitago.de.Their portfolio spans across Germany, United States, France and 6 more locations. They have invested in Life Sciences, Auto Tech, High Tech and 9 other sectors, across stages such as Series B, Series A and 3 more. Here is the list of top investments by PolyTechnos Venture Partners:Developer of oral small molecules for neurological disorders. The proprietary platform screens and identifies allosteric modulators. The product pipeline includes Diplaglurant for Parkinson's disease, specifically for Levodopa-induced Dyskinesia (PD-LID), ADX71149 for epilepsy, mGlu2 Nam for neurocognitive disorders, mGlu3 PAM Parkinson's disease, mGlu4 PAM for neurodegenerative disorders.
Key facts about Addex Therapeutics
- Founded Year: 2002
- Location: Geneva (Switzerland)
- Stage: Public
- Total Funding till date: $71M
- Employee Count: 30 as on Jul 01, 2024
- Investors: CAM Capital, Armistice Capital and 22 Others
- Latest Funding Round: Grant (prize money), Sep 20, 2023, $*****
- Highlight: Public
2. Innolume
Manufacturer of quantum‑dot and diode lasers for photonic applications. The company designs, develops, and produces a broad range of semiconductor laser diodes—including single‑mode, multi‑mode, distributed‑feedback, Fabry‑Pérot, and comb lasers—as well as optical amplifiers and turnkey systems. It operates a fully integrated production process from epitaxial wafer growth to packaging and module fabrication. Devices leverage GaAs-based quantum well and quantum dot technologies across wavelengths spanning near‑infrared ranges. Applications include medical diagnostics, optical communications, industrial processing, scientific research, and AI-related cloud networking. The platform supports customization for mid-volume and high-volume production, with in‑house characterization and quality assurance. Manufacturing is conducted in Germany with distributed global distribution and technical support.
Key facts about Innolume
- Founded Year: 2003
- Location: Dortmund (Germany)
- Stage: Series C
- Total Funding till date: $27.9M
- Employee Count: 39 as on Jul 01, 2024
- Investors: Applied Materials, KfW and 13 Others
- Latest Funding Round: Grant (prize money), Feb 01, 2020, $*****
- Highlight: Editors' Pick
3. ColorChip
Provider of application-specific photonic ICs for applications in data centres. It designs and manufactures optical sub-systems and components for the datacom and telecom markets. These sub-systems and components are based on application-specific photonic integrated circuits (ASPICs) that leverage the company's unique and robust PLC technology.
Key facts about ColorChip
- Founded Year: 2001
- Location: Yokneam Illit (Israel)
- Stage: Acquired
- Total Funding till date: $97.4M
- Employee Count: 63 as on Jul 01, 2024
- Investors: Scale Up Venture Capital, Walden Israel and 13 Others
- Latest Funding Round: Series C, Apr 06, 2017, $*****
- Highlight: Acquired
4. Jerini
Jerini was a late stage biotechnology firm developing Bradykinin hormone inhibitors. Firazyr (icatibant) was a late-stage orphan drug for hereditary angiodema-a rare genetic disease. Jerini was listed on the Frankfurt stock exchange in 2005 and in 2008 it was acquired by Shire Plc for the molcule Firazyr. The drug received FDA approval on August 25, 2011. The R&D assets of Jerini were bought by 3B Pharma in 2009.
Key facts about Jerini
- Founded Year: 1994
- Location: Berlin (Germany)
- Stage: Acquired
- Total Funding till date: $76.2M
- Investors: EQT, Signet Healthcare Partners and 11 Others
- Latest Funding Round: Series B, Feb 15, 2005, $*****
- Highlight: Acquired
5. nanotron
nanotron provides wireless products for location-aware wireless sensor networks, real-time location systems. Its embedded location platform consists of chips, modules, and software that enable precise real-time positioning and concurrent wireless communication. It has 3 products for the embedded location swarm, RTLS, transceiver. swarm products are mostly used for collaborative location, whereas RTLS products primarily provide solutions in fixed locations. The transceiver offers different levels of integration and serves as a basic key component of nanotron's other products.
Key facts about nanotron
- Founded Year: 1991
- Location: Berlin (Germany)
- Stage: Acquired
- Total Funding till date: $13.6M
- Employee Count: 25 as on Dec 31, 2018
- Investors: Zouk Capital, PolyTechnos Venture Partners and 4 Others
- Latest Funding Round: Series C, Jul 09, 2007, $*****
- Highlight: Acquired
PolyTechnos Venture Partners' Investments by Stage
PolyTechnos Venture Partners has made 6 investments in Series B stage with an average round size of $20.4M, 5 investments in Series A stage with an average round size of $10.3M, 4 investments in Series C stage with an average round size of $21.4M, 2 investments in Series D stage with an average round size of $12.1M and 1 investment in Seed stage with an average round size of $6.5M.Stage of entry | No. of Investments |
|---|---|
Series B | 6 |
Series A | 5 |
Series C | 4 |
Series D | 2 |
Seed | 1 |
Note: We have considered here, only first round of investments
PolyTechnos Venture Partners' Investments by Sector
PolyTechnos Venture Partners has a diverse portfolio, with companies operating in the Life Sciences, High Tech, Semiconductors, Auto Tech and Consumer. Notably, it has invested in 17 Enterprise (B2B) companies, 15 Tech companies, 6 Tech hardware companies and at least 4 companies focusing on Software.Sector | No. of Investments |
|---|---|
Life Sciences | 8 |
High Tech | 4 |
Semiconductors | 4 |
Auto Tech | 1 |
Consumer | 1 |
Others | 7 |
Note: We have considered here, only first round of investments
PolyTechnos Venture Partners' Investments by Geography
PolyTechnos Venture Partners has made most investments in Germany (4), followed by United States where it has made 3 investments.Country | No. of Investments |
|---|---|
Germany | 4 |
United States | 3 |
France | 2 |
Ireland | 2 |
Switzerland | 2 |
Others | 4 |
Note: We have considered here, only first round of investments
PolyTechnos Venture Partners' recent investments
PolyTechnos Venture Partners has not made any investment in 2026 so far.Here are the most recent investments by PolyTechnos Venture Partners:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
May 03, 2013 | France | Series A | 7766 | [+1] | |
Jun 15, 2009 | Ireland | Series C | 9000 | ||
Jun 02, 2009 | Ireland | Series C | 4361 | ||
Jan 12, 2009 | United States | Series C | 6532 | [+4] | |
Sep 17, 2007 | Switzerland | Series C | 7875 | [+3] |
IPOs and Publicly Listed companies in PolyTechnos Venture Partners' Portfolio
2 of PolyTechnos Venture Partners' portfolio companies have become public. Pixium Vision got listed on the Euronext Exchange (Euronext), in Jun 2014 at marketcap of $46.7M and Addex Therapeutics got listed on the SIX Swiss Exchange (SWX) at marketcap of $325M.Here are PolyTechnos Venture Partners' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jun 20, 2014 | May 03, 2013 | Series A | 6705 | |
May 25, 2007 | May 17, 2004 | Series B | 9515 |
Acquired companies in PolyTechnos Venture Partners' Portfolio
7 companies from PolyTechnos Venture Partners' portfolio have been acquired. The most recent acquisition were nanotron in Oct 2020 by Inpixon for $8.7M.Here are PolyTechnos Venture Partners' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Oct 05, 2020 | Jul 09, 2007 | Series C | 9683 | |
Aug 27, 2018 | Feb 21, 2001 | Seed | 4002 | |
Dec 15, 2013 | - | - | 1903 | |
May 23, 2011 | Jan 2005 | Series B | 5582 | |
Jul 12, 2010 | Sep 15, 2000 | Series D | 7766 |
Team profile of PolyTechnos Venture Partners
PolyTechnos Venture Partners has a team of 6 members including 6 Partners located in Germany and United States. PolyTechnos Venture Partners' team does not sit on the board of any company as of now.Here is a list of all team members in PolyTechnos Venture Partners:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Ambler | - | - | |
Partner | - | - | ||
Partner | - | - | - | |
Partner | Munich | - | - | |
Partner | Munich | - | - | |
Partner | Munich | - | - |
Co-investors of PolyTechnos Venture Partners
Over the past 26 years, 104 investors have co-invested in PolyTechnos Venture Partners's portfolio companies. This includes funds and angels.
- Invested before PolyTechnos Venture Partners: Sofinnova Partners and Alain Rodermann have invested in rounds before PolyTechnos Venture Partners. There is 1 company where Sofinnova Partners has invested before PolyTechnos Venture Partners and 1 company where Alain Rodermann has invested before PolyTechnos Venture Partners.
- Top Co-investors of PolyTechnos Venture Partners: 47 investors entered a company along with PolyTechnos Venture Partners. These include investors like Abingworth (2 companies).
- Invested after PolyTechnos Venture Partners: A total of 55 investors have invested in PolyTechnos Venture Partners's portfolio after their investments. Top Investors include Kreos Capital (4 companies), Sofinnova Partners (2 companies) and Europa (2 companies).
Recent News related to PolyTechnos Venture Partners
•
•
Sanofi to acquire BiPar SciencesStrategic Transactions•Apr 01, 2009•BiPar Sciences, Sanofi, Sanofi, BiPar Sciences and 6 others
•
•
ColorChip Closes $9.5 Million Financing RoundPR Newswire•Jan 12, 2006•ColorChip, Bessemer Venture Partners, Motorola Solutions, Walden Israel and 3 others
•
Fiber-to-the-home co ColorChip raises $7.2m - Globes
Globes•Jan 11, 2006•ColorChip, Bessemer Venture Partners, Motorola Solutions, Walden Israel and 3 others
•
Nanotron raises $10.3 million in funding roundEE times•nanotron, Zouk Capital, Danfoss, PolyTechnos Venture Partners and 1 other
•
Optical components startup ColorChip raises $6.5m - כללי - TheMarkerTheMarker•ColorChip, Walden Israel, Eurofund, PolyTechnos Venture Partners
•
Optical Keyhole: News itemOptical Keyhole•ColorChip, Bessemer Venture Partners, Motorola Solutions, Walden Israel and 3 others
•
ColorChip raises $6.5 mln at $17 mln company value - Globes
Globes•ColorChip, Walden Israel, Eurofund, PolyTechnos Venture Partners
•
Optical Keyhole: News itemOptical Keyhole•ColorChip, Bessemer Venture Partners, Eurofund, Walden Israel and 3 others
